145 related articles for article (PubMed ID: 37276931)
1. Drug reaction eosinophilia and systemic symptoms: Clinical phenotypic patterns according to causative drug.
Blumenthal KG; Alvarez-Arango S; Kroshinsky D; Lo YC; Samarakoon U; Salem AR; Fu X; Bassir F; Wang L; Jaggers J; Phillips E; Zhou L
J Am Acad Dermatol; 2024 Jun; 90(6):1240-1242. PubMed ID: 37276931
[No Abstract] [Full Text] [Related]
2. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):885-908. PubMed ID: 37516359
[TBL] [Abstract][Full Text] [Related]
3. Flares in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: a retrospective study.
Yang J; Che Q; Zhang C; Zhu Z; Qiao H; Fan P; Wang G; Fu M
Arch Dermatol Res; 2023 Dec; 316(1):8. PubMed ID: 38038749
[No Abstract] [Full Text] [Related]
4. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
[TBL] [Abstract][Full Text] [Related]
5. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
Gallardo MA; Mallela T; Gilkey T; Himed S; Walker TD; Nusbaum KB; Korman A; Trinidad J; Chung C; Kaffenberger BH
J Am Acad Dermatol; 2023 May; 88(5):1142-1145. PubMed ID: 36442643
[No Abstract] [Full Text] [Related]
6. Vancomycin-associated drug-induced hypersensitivity syndrome.
Madigan LM; Fox LP
J Am Acad Dermatol; 2019 Jul; 81(1):123-128. PubMed ID: 30738120
[TBL] [Abstract][Full Text] [Related]
7. Drug reaction with eosinophilia and systemic symptoms syndrome induced by benznidazole.
Moreno-Escobosa C; Cruz-Granados S
Contact Dermatitis; 2018 Aug; 79(2):105-106. PubMed ID: 29635801
[No Abstract] [Full Text] [Related]
8. Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome.
Blumenthal KG; Alvarez-Arango S; Fu X; Kroshinsky D; Choi H; Phillips E; Zhou L
JAMA Dermatol; 2022 Dec; 158(12):1449-1453. PubMed ID: 36322078
[TBL] [Abstract][Full Text] [Related]
9. Probable Griseofulvin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms in a Child.
Smith RJ; Boos MD; McMahon P
Pediatr Dermatol; 2016 Sep; 33(5):e290-1. PubMed ID: 27397873
[TBL] [Abstract][Full Text] [Related]
10. Anti-tubercular therapy causing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.
Saxena P; Chadha D; Goyal R
J R Coll Physicians Edinb; 2020 Dec; 50(4):414-415. PubMed ID: 33469620
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Clinical Case Report.
Varghese A; Alosious A; Thomas R; Surendran K; Vilapurathu JK
J Pharm Pract; 2024 Feb; 37(1):225-228. PubMed ID: 35924976
[TBL] [Abstract][Full Text] [Related]
12. Multiple Drug Hypersensitivity in a Small Child with DRESS Syndrome - A Case Report.
Gruber S; Gona-Hoepler L; Bangert C; Diesner SC; Schmidthaler K; Szepfalusi Z
Klin Padiatr; 2023 Jan; 235(1):52-54. PubMed ID: 35785803
[TBL] [Abstract][Full Text] [Related]
13. Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype.
Momen SE; Diaz-Cano S; Walsh S; Creamer D
J Am Acad Dermatol; 2021 Sep; 85(3):645-652. PubMed ID: 33872719
[TBL] [Abstract][Full Text] [Related]
14. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
15. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
16. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
Avancini J; Maragno L; Santi CG; Criado PR
Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
[TBL] [Abstract][Full Text] [Related]
17. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
18. Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Probably Related to Cefpodoxime: A Case Report.
Babu T; Panachiyil GM; Sebastian J; Shastry V
J Pharm Pract; 2021 Feb; 34(1):163-165. PubMed ID: 31382812
[TBL] [Abstract][Full Text] [Related]
19. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
[TBL] [Abstract][Full Text] [Related]
20. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Cho M; Hostoffer R
J Osteopath Med; 2023 Sep; 123(9):459-460. PubMed ID: 37382386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
